APA (7th ed.) Citation

Al-mansoori, L., Qahtani, A. D. A., Elsinga, P., & Goda, S. K. (2021). Production of Long-Acting CNGRC–CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment. SAGE Publishing.

Chicago Style (17th ed.) Citation

Al-mansoori, Layla, Alanod D. Al Qahtani, Philip Elsinga, and Sayed K. Goda. Production of Long-Acting CNGRC–CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment. SAGE Publishing, 2021.

MLA (8th ed.) Citation

Al-mansoori, Layla, et al. Production of Long-Acting CNGRC–CPG2 Fusion Proteins: New Derivatives to Overcome Drug Immunogenicity of Ligand-Directed Enzyme Prodrug Therapy for Targeted Cancer Treatment. SAGE Publishing, 2021.